PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference

WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 10, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022 at 8:45 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an overview on... Read more

Bruker Corporation to Present at the 11th Annual SVB Leerink Global Healthcare Conference

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 11th Annual SVB Leerink Global Healthcare Conference, being held virtually. Frank Laukien, Chairman, President & CEO will present on behalf of the Company on Wednesday, February 16th, 2022 at 8:40 AM Eastern Standard Time. A live audio webcast of the presentation... Read more

New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis

Thermo Fisher Scientific expands Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers CARLSBAD, Calif.–(BUSINESS WIRE)– Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis,is an important tool for improving clinical research and advancing scientific discovery. To further enable customers’ cutting-edge research in areas such as gene editing and infectious disease,... Read more

Bruker Enables High-Throughput Multiplex HTS on Sierra SPR Platform

Sierra Surface Plasmon Resonance (SPR) Pro Series for High-Throughput Screening (HTS) Innovative Sierra SPR-32 Pro allowing multiplex HTS for insights into kinetics with no compromise in sensitivity and nature of samples SPR insights into molecular interactions by label-free HTS in support of drug discovery BOSTON–(BUSINESS WIRE)– At the SLAS2022 International Conference and Exhibition, Bruker Corporation... Read more

Bruker Launches New timsTOF-based MALDI PharmaPulse® Solution for Label-free HTS in Drug Discovery

timsTOF MALDI PharmaPulse® (timsTOF MPP) for Unprecedented High-Throughput Screening (HTS) information content and throughput Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): Exploiting ion mobility separation as a new dimension in HTS combined with high resolution QTOF-MS Enabling new... Read more

Bruker Expands Nanoflow Consumables Portfolio for 4D-Proteomics™

Acquires PepSep NanoLC Columns and Components Company for ease-of-use and robustness Enters into OEM agreement with IonOpticks for high-performance nanoLC Aurora columns Complementary PepSep and IonOpticks nanocolumns enhance performance and robustness of timsTOF 4D-Proteomics ™ solutions PepSep packed nanocolumns for ease of use and robustness with Bruker CSI emitter IonOpticks Aurora columns with integrated emitter... Read more

PerkinElmer to Showcase Expanded Life Science / Cell & Gene Therapy Portfolios and Automated Genomic Workflows at SLAS 2022

End-to-end solutions designed to help scientists streamline and improvedrug discovery R&D productivity WHAT:  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is at SLAS 2022 on February 7-9 along with several of its new partner companies showcasing how its end-to-end life science solutions and automated workflows can accelerate scientists’ R&D productivity... Read more

Thermo Scientific Nicolet RaptIR FTIR Microscope Quickly Collects and Analyzes High-Spatial Resolution Data with Agility and Acuity

Thermo Scientific Nicolet RaptIR FTIR Microscope Quickly Collects and Analyzes High-Spatial Resolution Data with Agility and Acuity New instrument helps maximize lab productivity and extends FTIR to large, heavy samples HILLSBORO, Ore., Feb. 3, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Thermo Scientific Nicolet RaptIR FTIR Microscope. It... Read more

U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus

EUROIMMUN assay used to detect previous dengue virus infection will help children and adolescents gain access to vaccine WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 3, 2022– EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the U.S. Centers for Disease Control and Prevention... Read more